NCT06527729Early phase 1Completed
A Novel Formulation of Sildenafil-loaded Nanocarriers for Treatment of Alopecia Areata
Sildenafil-loaded Lipid-based Nanocarrier as a Potential Therapy for Alopecia Areata: A Randomized Clinical Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Early phase 1
- Sponsor
- Assiut University
- Participants (registry)
- 28
- Start
- July 2021
- Primary completion
- June 2022
- Study completion
- October 2022
- Last registry update
- July 2024
- Countries
- Egypt
Conditions studied: Alopecia Areata
Interventions: sildenafil-loaded liposomes, minoxidil gel
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.